Niva Bupa Health Insurance Receives IRDAI Show Cause Notice Following Regulatory Inspection
Niva Bupa Health Insurance Company Limited received a Show Cause Notice and Letter of advice from IRDAI on February 26, 2026, following a February 2025 inspection. The regulatory action addresses violations of master circulars related to health insurance business, policyholder protection, and corporate governance. The company is responding to IRDAI and implementing compliance measures, stating no current impact on financial or operational activities.

*this image is generated using AI for illustrative purposes only.
Niva bupa health insurance company Limited has received a Show Cause Notice (SCN) and Letter of advice from the Insurance Regulatory and Development Authority of India (IRDAI) following a regulatory inspection. The company disclosed this development to stock exchanges on February 27, 2026, as required under SEBI listing regulations.
Regulatory Inspection and Subsequent Actions
IRDAI conducted an inspection of the company during February 2025, following which it issued observations that were duly replied to by the company. On February 26, 2026, at 1751 Hrs (IST), IRDAI issued both the Show Cause Notice and Letter of advice via email. The SCN relates to business and operational aspects of the company, while the Letter of advice provides compliance measures that the company must implement.
Nature of Violations Identified
The regulatory action stems from violations of certain provisions across multiple IRDAI master circulars:
| Violation Category: | Details |
|---|---|
| Master Circular: | Health Insurance Business |
| Master Circular: | Protection of Policyholders Interest |
| Master Circular: | Corporate Governance |
| Authority: | Insurance Regulatory and Development Authority of India |
| Communication Type: | Letter of advice |
Company's Response and Impact Assessment
The company is currently in the process of submitting its response to IRDAI regarding the Show Cause Notice. Additionally, Niva Bupa Health Insurance is implementing necessary actions as advised in the Letter of advice to ensure compliance with regulatory requirements.
| Impact Assessment: | Status |
|---|---|
| Financial Impact: | None |
| Operational Impact: | None |
| Other Activities Impact: | None |
| Expected Financial Implications: | None |
| Penalty or Sanctions: | None |
Regulatory Compliance Disclosure
The company has fulfilled its disclosure obligations under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure includes detailed annexures providing comprehensive information about the regulatory communication, including the nature of violations and the company's response measures. Company Secretary and Compliance Officer Aparna Sharma signed the disclosure, confirming that the information provided is true, correct, and complete to the best of the company's knowledge and belief.
The company emphasized that there is no impact on financial, operational, or other activities arising from this regulatory action at this stage, and it remains committed to implementing the necessary compliance measures as advised by IRDAI.
Historical Stock Returns for Niva Bupa Health Insurance Company
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.82% | -1.29% | -2.48% | -9.93% | +1.86% | +1.45% |


































